综合医疗管理与冠脉血流储备指导的血运重建对比常规护理治疗慢性冠脉疾病:CENTURY试验
CENTURY随机试验纳入1028例慢性稳定性冠心病患者,比较综合强化生活方式与药物治疗(血运重建仅保留给PET显示冠脉血流储备严重降低者)与常规护理。综合护理组降低危险因素、5年风险评分、11年全因死亡、死亡或心梗、晚期血运重建及主要不良心脏事件。
要点
- 综合护理组较常规组显著降低5年风险评分(Δ-1.1 vs +0.33)。
- 综合护理组11年全因死亡(4.7% vs 8.2%)和死亡或心梗(7.0% vs 11.1%)更低。
- 仅5.4%患者90天内接受血运重建,且主要由CFC严重程度指导。
核心结论
- 综合整合生活方式调整和目标导向的药物治疗,并将血运重建保留给CFC严重降低者,可显著降低危险因素评分、死亡、死亡或心梗及血运重建。
研究设计与样本
- 随机对照试验,2009-2017年纳入515例综合护理组和513例标准护理组,随访5年或以上。
关键数值与推荐
- 血运重建仅保留给PET显示冠脉血流储备严重降低且死亡风险高的患者。
- 1028例患者中仅56例(5.4%)在90天内接受血运重建,且主要由CFC严重程度指导。
临床怎么用
- 对慢性稳定性冠心病患者,可采用综合强化生活方式与药物治疗,并以PET评估的CFC指导血运重建决策。
- 综合护理包括频繁门诊随访和24/7电话/邮件支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The randomized CENTURY trial tested the hypothesis that a comprehensive strategy integrating intense lifestyle modification and aggressive medical management to goals with revascularization reserved for severely reduced coronary flow capacity (CFC) by positron emission tomography (PET) would reduce risk factors, subsequent revascularization, death and myocardial infarction (MI) compared with standard of care in chronic stable coronary artery disease (CAD). METHODS: Participants were randomly assigned to standard or comprehensive care groups. Rest-stress PET quantified CFC for physiological CAD severity at baseline, 2, 5, and up to 11 years. The comprehensive care group reviewed PET results with frequent clinic visits and open 24/7 phone/email support. Standard care lacked supportive contact with blinded PET results that were unblinded only for severely reduced CFC with high mortality risk for potential revascularization. RESULTS: Between 2009-2017, 515 patients were assigned to comprehensive care and 513 to standard care and followed for 5 or more years. Comprehensive vs standard care decreased risk factors and summed 5-year risk score (Δ-1.1 vs + 0.33; 95% confidence interval -1.84 to -0.97; P < .0001), decreased cumulative 11-year all-cause death (4.7% vs 8.2%; P = .023), death or MI (7.0% vs 11.1%; P = .024) late revascularization (9.5% vs 14.8%; P = .021) and major adverse cardiac events (20.5% vs 29.9%; P = .0006). Only 56 of 1028 (5.4%) CENTURY patients with chronic CAD had revascularization within 90 days predominantly guided by CFC severity. CONCLUSIONS: The randomized CENTURY trial demonstrates that comprehensive integrated lifestyle modification and medical management towards goals with revascularization reserved for severely reduced CFC, significantly reduced risk factor scores, death, death or MI, and revascularization. CLINICALTRIALS.GOV: NCT00756379.
引用
- Gould KL, Johnson NP, Roby AE, et al. Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial. Eur Heart J. 2025. PMID: 40439159. doi:10.1093/eurheartj/ehaf356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。